Market Overview

UPDATE: Morgan Stanley Downgrades Blue Nile to Equal-Weight on Tempered Growth Outlook

Related NILE
Earnings Scheduled For August 7, 2015
Morning Market Losers
Blue Nile (NILE) Sees Hammer Chart Pattern: Time to Buy? (Zacks)

Morgan Stanley downgraded Blue Nile (NASDAQ: NILE) from Overweight to Equal-weight and removed the price target of $48.00.

Morgan Stanley commented, "Changing our rating to Equal-weight, relative to our coverage universe: We still like the company, but we believe the stock will perform more inline with its peers until it can show sustained acceleration of non-engagement sales. We are concerned that the ultimate cost of driving non-engagement sales may be higher than we expected. … We are reducing our base case fair value to $36, which is driven by a DCF valuation analysis assuming a 14% WACC and 4% perpetual growth rate."

Blue Nile closed at $30.30 on Wednesday.

Latest Ratings for NILE

Aug 2015RBC CapitalMaintainsSector Perform
Feb 2015Wells FargoDowngradesOutperformMarket Perform
Feb 2015Stephens & Co.UpgradesEqual-weightOverweight

View More Analyst Ratings for NILE
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Analyst Ratings


Related Articles (NILE)

Get Benzinga's Newsletters